JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


Anesth Analg 1990; 71:185-190
© 1990 International Anesthesia Research Society
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hawkins, J. L.
Right arrow Articles by Joyce, T. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hawkins, J. L.
Right arrow Articles by Joyce, T. H., III

Vecuronium for Rapid-Sequence Intubation for Cesarean Section

Joy L. Hawkins, MD, T. David Johnson, PhD, Martha A. Kubicek, RN, Barbara S. Skjonsby, RN, Dean H. Morrow, MD, and Thomas H. Joyce, III, MD

Department of Anesthesiology, Baylor College of Medicine, Houston, Texas.

Abstract

Because succinylcholine may occasionally be contraindicated for rapid-sequence induction in parturients, we studied the use of vecuronium in 21 patients having elective cesarean sections. Eleven patients (group 1) received 10 µg/kg vecuronium as a priming dose, followed 4–6 min later by 100 µg/kg. Ten patients (group 2) received 200 µg/kg vecuronium as a bolus. Onset, the time from the injection of vecuronium to maximal twitch suppression, and clinical duration, the time between vecuronium administration and return to 25% of the control twitch height, were recorded. Umbilical and maternal venous blood samples at delivery were analyzed for vecuronium concentrations. One-minute and 5-min Apgar scores and 1– and 24-h Neurologic and Adaptive Capacity Scores (NACS) were recorded. Individual tests of passive and active tone within the overall NACS profile were compared to evaluate further any residual vecuronium effects in the infants. Onset of neuromuscular blockade was 177 s in group 1 and 175 s in group 2. The corresponding clinical durations were 73 and 115 min. Maternal and umbilical venous vecuronium concentrations were 515 and 73 ng/mL in group 1 and 838 and 107 ng/mL in group 2. Seventy percent of neonates in group 1 had Apgar scores greater than 7 at 1 min, with 100% greater than 7 at 5 min. Corresponding values in group 2 infants were 50% and 80%. Fifty percent of group 1 infants had NACS of 35–40 at 1 h, and 70% at 24 h. Corresponding values in group 2 infants were 50% and 80%. These data suggest that the priming dose regimen for vecuronium administration may be a useful alternative for rapid-sequence induction for cesarean section when succinylcholine is contraindicated. However, the onset and clinical duration were longer than desired, and the NACS data suggested residual effects in the infants.

Key Words: NEUROMUSCULAR RELAXANTS, VECURONIUM • INDUCTION, ANESTHESIA-rapid sequence.




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
N. Kotani, T. Kushikata, H. Hashimoto, M. Muraoka, M. Tonosaki, and A. Matsuki
Rebound Perioperative Hyperkalemia in Six Patients After Cessation of Ritodrine for Premature Labor
Anesth. Analg., September 1, 2001; 93(3): 709 - 711.
[Abstract] [Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 1990 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 1990 by the International Anesthesia Research Society.